Orthofix Medical Inc. (NASDAQ:OFIX) Shares Purchased by Jane Street Group LLC

Jane Street Group LLC boosted its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 10.7% in the 3rd quarter, Holdings Channel reports. The fund owned 48,134 shares of the medical device company’s stock after acquiring an additional 4,647 shares during the quarter. Jane Street Group LLC’s holdings in Orthofix Medical were worth $752,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Victory Capital Management Inc. purchased a new stake in shares of Orthofix Medical in the second quarter valued at approximately $832,000. Charles Schwab Investment Management Inc. boosted its stake in Orthofix Medical by 14.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 324,807 shares of the medical device company’s stock worth $5,073,000 after buying an additional 39,901 shares during the last quarter. AYAL Capital Advisors Ltd grew its holdings in Orthofix Medical by 10.2% in the 2nd quarter. AYAL Capital Advisors Ltd now owns 686,794 shares of the medical device company’s stock valued at $9,107,000 after buying an additional 63,697 shares in the last quarter. Paradigm Capital Management Inc. NY increased its stake in shares of Orthofix Medical by 31.3% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 2,556,100 shares of the medical device company’s stock worth $33,894,000 after acquiring an additional 609,137 shares during the last quarter. Finally, HighTower Advisors LLC raised its holdings in shares of Orthofix Medical by 114.9% during the 3rd quarter. HighTower Advisors LLC now owns 89,183 shares of the medical device company’s stock worth $1,393,000 after acquiring an additional 47,680 shares during the period. Institutional investors and hedge funds own 89.76% of the company’s stock.

Analyst Upgrades and Downgrades

OFIX has been the subject of a number of analyst reports. Stifel Nicolaus raised shares of Orthofix Medical from a “hold” rating to a “buy” rating and upped their price objective for the company from $18.00 to $24.00 in a report on Friday, November 8th. Roth Mkm restated a “buy” rating and set a $22.00 price target (up previously from $20.00) on shares of Orthofix Medical in a report on Friday, November 8th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

Orthofix Medical Stock Down 1.1 %

Shares of NASDAQ:OFIX opened at $17.26 on Friday. The business has a 50-day moving average price of $18.07 and a 200 day moving average price of $16.46. Orthofix Medical Inc. has a 12-month low of $12.08 and a 12-month high of $20.73. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $659.57 million, a price-to-earnings ratio of -5.51 and a beta of 1.09.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.